Regeneron Pharmaceuticals, Inc. Email & Phone number of top level executives

Regeneron Pharmaceuticals, Inc.

Biotech

Regeneron Pharmaceuticals Inc. is a US-based biotechnology company that focuses on the discovery, development, and commercialization of innovative medicines for serious medical conditions. Founded in 1988, Regeneron has established itself as a leading player in the healthcare industry by leveraging cutting-edge science, technology, and human genetics. The company's platform technologies include VelociGene® for the rapid creation of mouse models of human diseases, VelocImmune® for the generation of fully human antibodies, and CRISPR/Cas9 gene editing for precise genetic modifications. Regeneron's flagship drug, EYLEA®, is a leading treatment for wet age-related macular degeneration and other retinal diseases. The company is also actively engaged in developing therapies for cancer, respiratory diseases, and immune-mediated disorders.